Long non-coding RNA AL139002.1 promotes gastric cancer development by sponging microRNA-490-3p to regulate Hepatitis A Virus Cellular Receptor 1 expression

References

• Nagano T, Fraser P. No-nonsense functions for long noncoding RNAs. Cell. 2011;145(2):178–181.
   PubMed Web of Science ®Google Scholar
• Garcia-Venzor A, Mandujano-Tinoco EA, Lizarraga F, et al. Microenvironment-regulated lncRNA-HAL is able to promote stemness in breast cancer cells. Biochim Biophys Acta Mol Cell Res. 2019;1866(12):118523..
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhao H, Zhang L, et al. Dandelion root extract suppressed gastric cancer cells proliferation and migration through targeting lncRNA-CCAT1. Biomed Pharmacother. 2017;93:1010–1017.
   PubMed Web of Science ®Google Scholar
• Li J, Meng H, Bai Y, et al. Regulation of lncRNA and its role in cancer metastasis. Oncol Res. 2016;23(5):205–217.
   PubMed Web of Science ®Google Scholar
• Kim J, Piao HL, Kim BJ, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018;50(12):1705–1715..
   PubMed Web of Science ®Google Scholar
• Ren J, Ding L, Zhang D, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Theranostics. 2018;8(14):3932–3948..
   PubMed Web of Science ®Google Scholar
• Han P, Li JW, Zhang BM, et al. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/beta-catenin signaling. Mol Cancer. 2017;16(1):9..
   PubMed Web of Science ®Google Scholar
• Wang H, Huo X, Yang XR, et al. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer. 2017;16(1):136..
   PubMed Web of Science ®Google Scholar
• Zhang G, Li S, Lu J, et al. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer. Mol Cancer. 2018;17(1):87..
   PubMedGoogle Scholar
• Luan X, Wang Y. LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p. J Gynecol Oncol. 2018;29(6):e95.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Ducreux M. Colorectal and gastric cancer in 2015: the development of new agents and molecular classifications. Nat Rev Clin Oncol. 2016;13(2):69–70.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer. Lancet. 2016;388(10060):2654–2664.
   PubMed Web of Science ®Google Scholar
• Wang XN, Liang H. Some problems in the surgical treatment of gastric cancer. Chin J Cancer. 2010;29(4):369–373.
   PubMedGoogle Scholar
• Xu G, Zhang Y, Li N, et al. LncRNA CCHE1 in the proliferation and apoptosis of gastric cancer cells. Eur Rev Med Pharmacol Sci. 2018;22(9):2631–2637.
   PubMed Web of Science ®Google Scholar
• Li Y, Wen X, Wang L, et al. LncRNA ZEB1-AS1 predicts unfavorable prognosis in gastric cancer. Surg Oncol. 2017;26(4):527–534..
   PubMed Web of Science ®Google Scholar
• Wang S, Chen W, Yu H, et al. lncRNA ROR Promotes Gastric Cancer Drug Resistance. Cancer Control. 2020;27(1):1073274820904694..
   Web of Science ®Google Scholar
• Hu M, Han Y, Zhang Y, et al. lncRNA TINCR sponges miR-214-5p to upregulate ROCK1 in hepatocellular carcinoma. BMC Med Genet. 2020;21(1):2.
   PubMed Web of Science ®Google Scholar
• Chen M, Wu X, Ma W, et al. Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance. Cancer Biomark. 2017;21(1):23–28..
   PubMed Web of Science ®Google Scholar
• Chen H, Xu Z, Liu X, et al. Increased Expression of Lncrna RP11-397A15.4 in Gastric Cancer and Its Clinical Significance. Ann Clin Lab Sci. 2018;48(6):707–711.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhang Z, Zhang Y, et al. HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway. Cancer Biol Ther. 2015;16(4):511–517..
   PubMed Web of Science ®Google Scholar
• Xue J, Li Y, Yi J, et al. HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome. Gastroenterol Res Pract. 2019;2019:6746970.
   PubMed Web of Science ®Google Scholar
• Sun TT, He J, Liang Q, et al. LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern. Cancer Discov. 2016;6(7):784–801..
   PubMed Web of Science ®Google Scholar
• Li D, Yang M, Liao A, et al. Linc00483 as ceRNA regulates proliferation and apoptosis through activating MAPKs in gastric cancer. J Cell Mol Med. 2018; 22(8):3875–3886..
   Web of Science ®Google Scholar
• Liu XH, Sun M, Nie FQ, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13(1):92..
   PubMed Web of Science ®Google Scholar
• Ou Y, He J, Liu Y. MiR-490-3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma. IUBMB Life. 2018;70(6):468–478.
   PubMed Web of Science ®Google Scholar
• Liu X, He B, Xu T, et al. MiR-490-3p Functions As a Tumor Suppressor by Inhibiting Oncogene VDAC1 Expression in Colorectal Cancer. J Cancer. 2018;9(7):1218–1230..
   PubMed Web of Science ®Google Scholar
• Kang NN, Ge SL, Zhang RQ, et al. MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2. Eur Rev Med Pharmacol Sci. 2018;22(23):8298–8305.
   PubMed Web of Science ®Google Scholar
• Wang B, Yin M, Cheng C, et al. Decreased expression of miR4903p in colorectal cancer predicts poor prognosis and promotes cell proliferation and invasion by targeting RAB14. Int J Oncol. 2018;53(3):1247–1256..
   PubMed Web of Science ®Google Scholar
• Qu M, Li L, Zheng WC. Reduced miR-490-3p expression is associated with poor prognosis of Helicobacter pylori induced gastric cancer. Eur Rev Med Pharmacol Sci. 2017;21(15):3384–3388.
   PubMed Web of Science ®Google Scholar
• Luo M, Liang C. LncRNA LINC00483 promotes gastric cancer development through regulating MAPK1 expression by sponging miR-490-3p. Biol Res. 2020;53(1):14.
   PubMed Web of Science ®Google Scholar
• Shen J, Xiao Z, Wu WK, et al. Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis. Cancer Res. 2015;75(4):754–765..
   PubMed Web of Science ®Google Scholar
• Cuadros T, Trilla E, Sarro E, et al. HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome. Cancer Res. 2014;74(5):1416–1428..
   PubMed Web of Science ®Google Scholar
• Wang Y, Martin TA, Jiang WG. HAVcR-1 expression in human colorectal cancer and its effects on colorectal cancer cells in vitro. Anticancer Res. 2013;33(1):207–214.
   PubMed Web of Science ®Google Scholar
• Xu J, Sun L, Sun W, et al. Targeted silencing of Kim-1 inhibits the growth of clear cell renal cell carcinoma cell line 786-0 in vitro and in vivo. Oncol Res. 2018;26(7):997–1003.
   PubMed Web of Science ®Google Scholar
• Deschenes-Simard X, Kottakis F, Meloche S, et al. ERKs in cancer: friends or foes? Cancer Res. 2014;74(2):412–419.
   PubMed Web of Science ®Google Scholar
• Liu H, Mei D, Xu P, et al. YAP promotes gastric cancer cell survival and migration/invasion via the ERK/endoplasmic reticulum stress pathway. Oncol Lett. 2019;18(6):6752–6758.
   PubMed Web of Science ®Google Scholar
• Bu X, Zhang A, Chen Z, et al. Migration of gastric cancer is suppressed by recombinant Newcastle disease virus (rL-RVG) via regulating alpha7-nicotinic acetylcholine receptors/ERK- EMT. BMC Cancer. 2019;19(1):976..
   PubMed Web of Science ®Google Scholar